![Sharon Wanjala](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ursprung des Netzwerks ersten Grades von Sharon Wanjala
Einheit | Art der Einheit | Industrie | |
---|---|---|---|
Serenus Biotherapeutics, Inc.
![]() Serenus Biotherapeutics, Inc. Medical DistributorsDistribution Services Serenus Biotherapeutics, Inc. distributes and manufactures pharmaceutical drug products. The company is headquartered in San Francisco, CA.
1
| Subsidiary | Medical Distributors | 1 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Sharon Wanjala
Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
---|---|---|---|
Athena Neurosciences LLC
![]() Athena Neurosciences LLC Miscellaneous Commercial ServicesCommercial Services Athena Neurosciences LLC operates as a research-based pharmaceutical company committed to the field of neurology. It develops therapeutic and diagnostic products. The company was founded by David Rowley-Jones, Larry C. Fritz, and Larry A. Bock in 1986 and is headquartered in Allegan, MI. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Impax Laboratories LLC
![]() Impax Laboratories LLC Pharmaceuticals: MajorHealth Technology Impax Laboratories LLC operates as a technology based specialty pharmaceutical company. It engages in the development, manufacture, and marketing of controlled-release and niche generics. The company was founded on December 14, 1999 and is headquartered in Bridgewater, NJ. | Pharmaceuticals: Major | Director/Board Member | |
Blueprint Genetics, Inc.
![]() Blueprint Genetics, Inc. Miscellaneous Commercial ServicesCommercial Services Athena Diagnostics, Inc. provides clinical diagnostics testing laboratory services. The firm focuses on neurology, endocrinology, hearing loss and nephrology. It offers tests for Alzheimer's disease, muscular dystrophy and other neuromuscular and developmental disorders. The company was founded in 1988 and is headquartered in Marlborough, MA. | Miscellaneous Commercial Services | Chief Executive Officer | |
Elan Pharmaceuticals, LLC
![]() Elan Pharmaceuticals, LLC Pharmaceuticals: MajorHealth Technology Elan Pharmaceuticals LLC develops and manufactures pharmaceutical products. It specializes in treatment of neurological and autoimmune diseases. The firm's drugs are used in the treatment of for Alzheimer's, Parkinson's, and rheumatoid arthritis diseases. The company is headquartered in South San Francisco, CA. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Harvard University
![]() Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Corporate Officer/Principal | |
BioVision, Inc.
![]() BioVision, Inc. Pharmaceuticals: MajorHealth Technology BioVision, Inc. manufactures pharmaceutical products for apoptosis and cell signaling. It offers assay kits, antibodies, and recombinant proteins and enzymes. The company is headquartered in Milpitas, CA. | Pharmaceuticals: Major | Chief Executive Officer | |
University of Cambridge | College/University | Doctorate Degree | |
The University of North Carolina at Chapel Hill | College/University | Undergraduate Degree | |
Minerva Healthcare, Inc. | Chief Executive Officer | ||
A-CUBE, Inc.
![]() A-CUBE, Inc. BiotechnologyHealth Technology A-CUBE, Inc. develops novel antibodies. It utilizes silico algorithms and to discover novel druggable targets suitable for developing human therapeutic interventions, including next generation drugs for commercially proven targets. The company was founded by Nobuyuki Ota is headquartered in Belmont, CA. | Biotechnology | Chairman | |
G2B Pharma, Inc.
![]() G2B Pharma, Inc. Pharmaceuticals: MajorHealth Technology G2B Pharma, Inc. focuses on the development of nasally delivered drugs, including nasally delivered epinephrine for the treatment of anaphylaxis. Its product anaphylaxis, a severe and life-threatening allergic reaction that can include rash, swelling of the tongue and throat, and a sudden drop in blood pressure. The company was founded by Nigel Ten Fleming and Mike Doodson and is headquartered in Corte Madera, CA. | Pharmaceuticals: Major | Chief Executive Officer | |
Minoryx Therapeutics SL
![]() Minoryx Therapeutics SL BiotechnologyHealth Technology Minoryx Therapeutics SL engages in the development of drugs for the orphan genetic diseases of the central nervous system. The company was founded by Marc Martinell, Joan Aymami, Nigel Ten Fleming and Xavier Barril in 2011 and is headquartered in Barcelona, Spain. | Biotechnology | Founder | |
Adventura Capital SL | Chief Executive Officer | ||
Boston University School of Medicine | College/University | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 15 |
Spanien | 4 |
Vereinigtes Königreich | 2 |
Sektoral
Health Technology | 8 |
Commercial Services | 5 |
Consumer Services | 5 |
Operativ
Chief Executive Officer | 6 |
Founder | 6 |
Director/Board Member | 5 |
Chairman | 5 |
Corporate Officer/Principal | 3 |
Am stärksten vernetzte Beziehungen
Insiders | |
---|---|
Nigel Ten Fleming | 19 |
- Börse
- Insiders
- Sharon Wanjala
- Unternehmensverbindungen